1887

Abstract

Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat (LTR) revealed a novel cis-acting positive and a negative regulatory element in the U3 region, located upstream of the enhancer-promoter region. These elements acted in a cell type-specific manner, being most active in human lymphocytic CEM cells, more active in Jurkat cells than in human monocytic U937 cells and least active in epithelioid HeLa cells. The down-modulatory effect of the negative regulatory element was abolished by HIV-2 Tat, suggesting the involvement of upstream DNA elements in optimal Tat-mediated trans-activation. The sequence elements that respond to T cell activation signals were also located in the upstream U3 region. Notably, the magnitude of the effect of the upstream regulatory elements depended on the basal activity of the LTR, which was also cell type-dependent. This emphasizes the importance of the cell-specific transcriptional factors and other effectors in regulating HIV gene expression. These observations may be relevant to the cell type-specific restriction of virus replication .

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-9-2253
1994-09-01
2022-01-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/9/JV0750092253.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-9-2253&mimeType=html&fmt=ahah

References

  1. Arya S. K. 1988; Human and simian immunodeficiency retroviruses: activation and differential transactivation of gene expression. AIDS Research and Human Retroviruses 4:175–186
    [Google Scholar]
  2. Arya S. K. 1990; Human immunodeficiency virus type-2 gene expression: two enhancers and their activation by T-cell activators. New Biologist 2:57–65
    [Google Scholar]
  3. Arya S. K. 1991; Human immunodeficiency virus type 2 (HIV-2) gene expression. Downmodulation by sequence elements downstream of the transcriptional initiation site. AIDS Research and Human Retroviruses 7:1007–1014
    [Google Scholar]
  4. Arya S. K. 1993; Human immunodeficiency virus type-2 (HIV-2) transactivator (Tat): functional domains and the search for transdominant negative mutants. AIDS Research and Human Retroviruses 9:839–845
    [Google Scholar]
  5. Arya S. K., Gallo R. C. 1988; Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements. Proceedings of the National Academy of Sciences U.S.A: 859753–9757
    [Google Scholar]
  6. Arya S. K., Sadaie M. R. 1993; Fusogenicity of mutant and chimeric proviruses derived from moelcular clones of cytopathic and non-cytopathic human immunodeficiency virus type 2. Journal of Acquired Immune Deficiency Syndromes 6:1205–1211
    [Google Scholar]
  7. Arya S. K., Sethi A. 1990; Stimulation of the human immunodeficiency virus type 2 (HIV-2) gene expression by the cytomegalovirus and HIV-2 transactivator gene. AIDS Research and Human Retroviruses 6:649–658
    [Google Scholar]
  8. Arya S. K., Guo C., Josephs S. F., Wong-Staal F. 1985; Transactivator gene of human T-lymphotropic virus type III (HTLV- III). Science 229:69–73
    [Google Scholar]
  9. Arya S. K., Beaver B., Jagodzinski L., Ensoli B., Kanki P. J., Albert J., Fenyo E. M., Biberfeld G., Zagury J. F., Laure F., Essex M., Norby E., Wong-Staal F., Gallo R. C. 1987; New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature; London: 328548–550
    [Google Scholar]
  10. Berkhout B., Jeang K. T. 1992; Functional roles of the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. Journal of Virology 66:139–149
    [Google Scholar]
  11. Berkhout B., Gatignol A., Rabson A. B., Jeang K. T. 1990; TAR-independent activation of the HIV-1 LTR: evidence that Tat requires specific regions of the promoter. Cell 62:757–767
    [Google Scholar]
  12. Dufoort G., Courouce A. M., Ancelle-Park R., Bletry O. 1988; No clinical signs 14 years after HIV-2 transmission via blood transfusion. Lancet ii:510
    [Google Scholar]
  13. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. 1993; Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature; London: 362359–362
    [Google Scholar]
  14. Emerman M., Guyader M., Montagnier L., Baltimore D., Muesing M. A. 1987; The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO Journal 6:3755–3760
    [Google Scholar]
  15. Evans L. A., Moreau J., Odehouri K., Legg H., Barboza A., Cheng-Mayer C., Levy J. A. 1988; Characterization of noncytopathic HIV-2 strain with unusual effects on CD4 expression. Science 240:1522–1525
    [Google Scholar]
  16. Fauci A. S. 1988; The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617–622
    [Google Scholar]
  17. Fenrick R., Malim M. H., Hauber J., Lee S. Y., Maizel J., Cullen B. R. 1989; Functional analysis of the Tat trans activator of human immunodeficiency virus type 2. Journal of Virology 63:5006–5012
    [Google Scholar]
  18. Guyader M., Emerman M., Sonigo P., Clavel F., Montagnier L., Alizon M. 1987; Genome organization and trans-activation of HIV-2. Nature 326:662–669
    [Google Scholar]
  19. Hauber J., Cullen B. R. 1988; Mutational analysis of the transactivation-responsive region of the human immunodeficiency virus type 1 long terminal repeat. Journal of Virology 62:673–679
    [Google Scholar]
  20. Hoxie J. A., Brass L. F., Pletcher C. H., Haggarty B. S., Collman R., Hahn B. 1991; Derivation and characterization of cytopathic variants of an alternate isolate of HIV-2: evidence for alterations in CD4-envelope affinity. Journal of Virology 65:5096–5101
    [Google Scholar]
  21. Kessler M., Mathews M. B. 1991; Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication. Proceedings of the National Academy of Sciences U.S.A: 8810018–10022
    [Google Scholar]
  22. Kong L. I., Lee S. W., Kappes J. C., Parkin J. S., Decker W. D., Hoxie J. A., Hahn B. H., Shaw G. M. 1988; West African HIV-2 related human retrovirus with attenuated cytopathicity. Science 240:1525–1529
    [Google Scholar]
  23. Kumar P., Hui H., Kappes J. C., Haggarty B. S., Hoxie J. A., Arya S. K., Shaw G. M., Hahn B. H. 1990; Molecular characterization of an attenuated isolate of HIV-2. Journal of Virology 64:890–901
    [Google Scholar]
  24. Laspia M. F., Rice A. P., Mathews M. B. 1989; HIV-1 Tat protein increases transcription initiation and stabilizes elongation. Cell 59:283–292
    [Google Scholar]
  25. Leiden J. M., Wang C. Y., Petryniak B., Markovitz D. M., Nabel G. J., Thompson C. B. 1992; A novel ets-related transcriptional factor, elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T-cells. Journal of Virology 66:5890–5897
    [Google Scholar]
  26. Lu X., Welsh T. M., Peterlin B. M. 1993; The human immunodeficiency virus type 1 long terminal repeat specifies two different transcriptional complexes, only one of which is regulated by Tat. Journal of Virology 67:1752–1760
    [Google Scholar]
  27. Markovitz D. M., Hannibal M., Perez V. L., Gauntt C., Folks T. M., Nabel G. J. 1990; Differential regulation of human immunodeficiency viruses (HIVs): a specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor. Proceedings of the National Academy of Sciences U.S.A: 879098–9102
    [Google Scholar]
  28. Markovitz D. M., Smith M. J., Hilfinger J., Hannibal M. C., Petryniak B., Nabel G. J. 1992; Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and KB regulatory elements. Journal of Virology 66:5479–5484
    [Google Scholar]
  29. Marlink R. G., Ricard D., M’Boup S., Kanki P. J., Romet-Lemonne J. L., N’Doye I., Diop K., Simpson M. A., Greco F., Chou M. J., Essex M. 1988; Clinical, hematologic and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type 2 (HIV-2). AIDS Research and Human Retroviruses 4:137–148
    [Google Scholar]
  30. Nabel G., Baltimore D. 1987; An inducible transcription factor activates expression of human immunodeficiency virus in T-cells. Nature; London: 326711–713
    [Google Scholar]
  31. Olsen H. S., Rosen C. A. 1992; Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. Journal of Virology 66:5594–5597
    [Google Scholar]
  32. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Kotler D. P., Fauci A. S. 1993; HIV infection is active and progressive in lymphoid tissue during the clinically latent stages of disease. Nature; London: 362355–358
    [Google Scholar]
  33. Poulsen A. G., Kvinesdal B., Anaby P., Molbak K., Frederiken K., Dias F., Lauritzen E. 1989; Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet i:827–831
    [Google Scholar]
  34. Rosen C. A., Sodroski J. G., Haseltine W. A. 1985; The location of cw-acting regulatory sequences in the human T-cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813–823
    [Google Scholar]
  35. Tong-Starksen S. E., Luciw P. A., Peterlin B. M. 1987; Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proceedings of the National Academy of Sciences U.S.A.: 846845–6849
    [Google Scholar]
  36. Tong-Starksen S. A., Welsh T. M., Peterlin B. M. 1990; Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to cell activation signals. Journal of Immunology 145:4348–4354
    [Google Scholar]
  37. Zagury D., Bernard J., Leonard R., Cheynier R., Feldman M., Sarin P. S., Gallo R. C. 1986; Long term cultures of HTLV-III infected cells: a model of cytopathology of T-cell depletion in AIDS. Science 231:850–853
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-9-2253
Loading
/content/journal/jgv/10.1099/0022-1317-75-9-2253
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error